SPEAKERS

Andres Hernandez de la Peña

Principal Scientist

Neomorph

Andrew Potterton

Head of Technology Platform

Adhesion Therapeutics

Benedict Cross

Chief Technology Officer & Head of Platform

PhoreMost

Bin Liu

Chief Executive Officer

HB Therapeutics, Inc.

Bradlee Heckmann

Co-founder & Chief Scientific Officer

ASHA therapeutics

Dmitri Ivanov

Associate Professor Biochemistry & Structural Biology

University of Texas Health San Antonio

Dong Seok Kim

Chief Executive Officer

AevisBio Inc.

Fan Liu

Co-Founder & Chief Technology Officer

NeoX Biotech Inc.

Felix Hausch

Professor

Technical University of Darmstadt

Feng Wang

Senior Principal Scientist & Lab Head Protein Homeostasis Discovery Sciences

Pfizer

Jacob Hale

Senior Scientist

Novartis

Julia Dou

Director of Protein Chemistry

Degron Therapeutics

Markus Queisser

Scientific Director

GlaxoSmithKline Plc

Matthew Hayward

Vice President of Drug Discovery

Magnet Biomedicine

Matthias Brand

Chief Technology Officer

Proxygen GmbH

Meizhong Jin

Senior Director – Oncology Chemistry

AstraZeneca

Peggy Thompson

Vice President & Head of Biology

Plexium Inc.

Rana Quraishi

CEO

Isoprene Pharmaceuticals

Rick Ewing

Vice President & Head of Chemistry

Rapafusyn Pharmaceuticals

Tauseef Butt President & Chief Executive Officer Progenra

Tauseef Butt

President & Chief Executive Officer

Progenra

Vivek Vishnudas

Vice President - Drug Discovery Non Clinical Development, Chief Technology Officer, Site Head of Research & Development

BPGBio Inc.

Yao Wang

Chief Medical Officer

Kangpu Biopharmaceuticals

FULL EVENT GUIDE
REGISTER
PARTNER